FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes the novel derivatives of 1,2,5-thiadiazole or its quaternized form taken among compounds of the general formula (I) where W means oxygen or sulfur atom; R is taken among the group consisting of hydrogen, halogen atom, R4,-OR4,-SR4,-SO2R4 and -Z-C4-12-(cycloalkylalkyl); R4 is taken among the group consisting of C1-15-alkyl, C2-15-alkenyl and C2-15-alkynyl each of that is substituted optionally with one or more substituents taken independently among the group consisting of halogen atom, -CF3, phenyl and phenoxy-group where phenyl and phenoxy-group are substituted optionally with one or more substituents taken independently among the group consisting of halogen atom, -CN, C1-4-alkyl, C1-4-alkoxy-group, -OF3,-CF3 or R is taken among the group consisting of -OR5Y,-SR5Y,OR5-Z-Y,-SR5ZY,-O-R5-Z-R4 where Z means oxygen or sulfur atom; R5 means C1-15-alkyl; Y means 5- or 6-membered heterocyclic group taken among thienyl, pyridyl and thiazolidonyl; G is taken among azacyclic or azabicyclic ring system or G means optionally substituted C3-C8-cycloalkyl where cycloalkyl substituents are taken among R1 and R2 or optionally substituted C1-6-alkyl where substituent is NR5R7; R6 and R7 both mean hydrogen atom or C1-6-alkyl; one of R1 and R1 means hydrogen atom and another means hydrogen atom or C1-6-alkyl; R3 means hydrogen atom or C1-5-alkyl; m = 0, 1 or 2; p = 0, 1 or 2; q = 1 or 2; r = 0, 1 or 2; means a single or double bond under condition that if W means oxygen atom and G means alkyl then R is taken among the group consisting of hydrogen atom, R4,-OR4,-SR4,-SO2R4,-Z-C4-12-(cycloalkylalkyl) each of that is optionally substituted with one or more substituents taken independently among the group consisting of halogen atom and -CF3; or R is taken among the group consisting of OR5Y,-SR5Y,OR5-Z-Y,-SR5ZY,-O-R5-Z-R4 where Z means oxygen or sulfur atom; R5 means C1-5-alkyl. Invention relates to also its pharmaceutically acceptable salt or solvate. Invention relates to therapeutic active azacyclic or azabicyclic compounds, method of their synthesis and pharmaceutical compositions including indicated compounds. New compounds are useful for treatment of patients with diseases of central nervous system caused by dysfunction of muscarine cholinergic system. EFFECT: new compounds indicated above, improved methods of synthesis, valuable pharmacological properties. 24 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
0 |
|
SU1777602A3 | |
USE OF 6-HETEROCYCLO-4-AMINO-1,3,4,5-TETRAHYDROBENZ[CD]INDOLE USED IN VOMITING OR NAUSEA AT MOVING, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2138262C1 |
PIPERIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY AS ANTAGONIST OF OPIOID PERIPHERAL ACTION | 1992 |
|
RU2076863C1 |
6-HETEROCYCLIC SUBSTITUTED 4-AMINO-1,2,2A,3,4-HEXAHYDROBENZ-[CD]-INDOLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHOD FOR THEIR PRODUCTION | 1992 |
|
RU2062775C1 |
4-AMINO-6-SUBSTITUTED TETRAHYDROBENZ-[C,D]-INDOLES | 1992 |
|
RU2073672C1 |
METHOD OF SYNTHESIS OF 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALT | 1989 |
|
RU2014330C1 |
RING SUBSTITUTED 2-AMINO-1,2,3,4-TETRAHYDRO NAPHTHALENES OR 3-AMINOCHROMATES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID ADDITIVE SALTS AND METHOD FOR THEIR PRODUCTION | 1992 |
|
RU2057751C1 |
IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2110515C1 |
METHOD OF SYNTHESIS OF (S)--1÷1-N,N-DIMETHYL-3-(1-NAPHTHALINYL- -HYDROXY)-3-(2-THIENYL)-PROPANEAMINE AND (S)-±-N,N-DIMETHYL- -3-(1-NAPHTHALINYLHYDROXY)-3-(2-THIENYL)-PROPANEAMINE PHOSPHATE | 1994 |
|
RU2127269C1 |
USE OF ISOXAZOLE DERIVATIVES FOR TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME (MUCOUS COLITIS) AND A PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2127111C1 |
Authors
Dates
2000-10-27—Published
1995-10-23—Filed